Wednesday, October 28, 2026
Data from SEC filings, checked daily
Public filings, plainly told
WallStPal · PDF guide
STOK Insider Trading and Fund Holdings (Stoke Therapeutics, Inc.) · https://wallstpal.com/stock/stok/ · saved 2026-10-28

About this page

Insider trades reported on SEC Form 4: when the people who run a company buy or sell its shares with their own money.

How to read it

Form 4
The form a company insider (officer, director or owner of more than 10%) must file with the SEC within two business days of buying or selling the company's shares.
Buy (P) and Sell (S)
Open-market purchases and sales. Gifts, option exercises and automatic tax withholding are left out because they say little about what the insider thinks.
Value
Shares times price, as reported on the filing.
10b5-1
A trade made under a plan set up in advance. Planned sales are common and usually say less than an unplanned purchase.
Late filing
A Form 4 filed more than two business days after the trade.
Vs. S&P 500
How the stock did after the trade minus how the overall market did in the same weeks.

A real example

In January 2016, when bank stocks were falling, JPMorgan Chase CEO Jamie Dimon bought 500,000 JPMorgan shares with his own money, worth about $26 million. His Form 4 made the purchase public within days, and investors read it as a strong sign of confidence.

Explain it like I'm 13

If the coach of a team bets his own allowance that his team will win, that tells you something. A Form 4 is the note a company boss must hand in whenever he buys or sells his own company's shares, so everyone can see it.

Data from public SEC filings and congressional reports. Information, not investment advice. Check every number against the filing linked on the page.

Summarize with AIChatGPTClaudePerplexityGoogle AIGrokCopilot
StockCIK 1623526

Stoke Therapeutics, Inc. (STOK): Insider Trades and Fund Holdings

In the past 12 months, Stoke Therapeutics, Inc. insiders reported no open-market purchases and 9 sales worth $1.35M; 6 of the sales were reported as made under a 10b5-1 trading plan.

0Insider buys, 12 months
$0Bought by insiders, 12 months
$1.35MSold by insiders, 12 months
0Tracked funds holding

Timeline: news and trades

Company filings (8-K), insider trades, notices of planned sales (Form 144), Congress trades and fund moves in the past year, newest first.

  1. Oct 21, 2026Planned saleEDWARD KAYE (former affiliate) filed notice to sell about $38.4 million around Oct 21, 2026
  2. Oct 2, 2026Insider saleGeneral Counsel Jonathan Allan sold $16,509 under a 10b5-1 plan (7 days after: executive or director change)
  3. Oct 2, 2026Planned saleJONATHAN D ALLAN (officer) filed notice to sell about $16,308 around Oct 2, 2026
  4. Oct 1, 2026Insider saleCHIEF MEDICAL OFFICER Barry Ticho sold $27,494 under a 10b5-1 plan (6 days after: executive or director change)
  5. Sep 25, 2026NewsCompany reported: Executive or director change
  6. Sep 1, 2026Insider saleCHIEF MEDICAL OFFICER Barry Ticho sold $170,061 under a 10b5-1 plan
  7. Aug 18, 2026Insider saleDirector Edward M. Md Kaye sold $402,528
  8. Aug 18, 2026Insider saleCHIEF MEDICAL OFFICER Barry Ticho sold $152,690
  9. Aug 18, 2026Insider saleGeneral Counsel Jonathan Allan sold $91,640
  10. Aug 3, 2026Insider saleCHIEF MEDICAL OFFICER Barry Ticho sold $208,385 under a 10b5-1 plan
  11. Jul 1, 2026Insider saleCHIEF MEDICAL OFFICER Barry Ticho sold $236,068 under a 10b5-1 plan
  12. Jun 16, 2026Insider saleGeneral Counsel Jonathan Allan sold $43,637 under a 10b5-1 plan

Recent insider trades

Open-market purchases (code P) and sales (code S) from Form 4. Grants, option exercises and gifts are not shown. Latest filing: Oct 2, 2026.

Recent STOK insider trades
FiledTradedInsiderRoleTypeSharesPrice ($)ValueHoldingFiling
Oct 2Oct 1Barry TichoCHIEF MEDICAL OFFICERCHIEF MEDICAL OFFICER▼ SELL10b5-11,05126.16$27K−5.2%Form 4 ↗
Oct 2Oct 2Jonathan AllanGeneral CounselGeneral Counsel▼ SELL10b5-162726.33$17K−3.0%Form 4 ↗
Sep 3Sep 1Barry TichoCHIEF MEDICAL OFFICERCHIEF MEDICAL OFFICER▼ SELL10b5-15,54530.67$170K−22%Form 4 ↗
Aug 18Aug 18Edward M. Md KayeDirectorDirector▼ SELL12,56732.03$403K−9.2%Form 4 ↗
Aug 18Aug 18Barry TichoCHIEF MEDICAL OFFICERCHIEF MEDICAL OFFICER▼ SELL4,76732.03$153K−16%Form 4 ↗
Aug 18Aug 18Jonathan AllanGeneral CounselGeneral Counsel▼ SELL2,86132.03$92K−12%Form 4 ↗
Aug 5Aug 3Barry TichoCHIEF MEDICAL OFFICERCHIEF MEDICAL OFFICER▼ SELL10b5-17,17629.04$208K−26%Form 4 ↗
Jul 6Jul 1Barry TichoCHIEF MEDICAL OFFICERCHIEF MEDICAL OFFICER▼ SELL10b5-17,22832.66$236K−21%Form 4 ↗
Jun 18Jun 16Jonathan AllanGeneral CounselGeneral Counsel▼ SELL10b5-11,45729.95$44K−7.5%Form 4 ↗
Source: SEC Form 4 filings, retrieved Oct 28, 2026. How we read filings

Insiders who traded in the past year

InsiderRoleBuysBoughtSellsSoldLatest
Barry TichoCHIEF MEDICAL OFFICER0$05$795KOct 2, 2026
Jonathan AllanGeneral Counsel0$03$152KOct 2, 2026
Edward M. Md KayeDirector0$01$403KAug 18, 2026
Filing quality

A All 9 insider trades reported on time. How it is graded

Reading these numbers

Insiders sell for many reasons: taxes, diversification, a house. Purchases with their own money are rarer and are usually read as more informative. A Form 4 is due within two business days of the trade. How to read a Form 4 →